click below
click below
Normal Size Small Size show me how
parathyroid gland
ch 18 therapeutic agents for the endocrine system, pharm tech
| Question | Answer |
|---|---|
| hyperparathyroidism | stems from increased PTH, parathyroid hormone, secretion in the bloodstream; increased PTH levels promote calcium release from the bones into the bloodstream which leads to bone weakening |
| medications for hyperparathyroidism | osteoporosis medications such as bisphosphonates, raloxifene, estrogen/progestin therapy, calcimimetics and vitamin D analogues |
| Calcijex or Rocaltrol | calcitriol *vitamin D analogues |
| Hectorol | doxercalciferol *vitamin D analogs |
| Zemplar | paricalcitol *vitamin D analogues |
| Sensipar | cinacalcet *calcimimetics |
| Evista | raloxifene *Selective Estrogen Serum Modulators (SERM) |
| hypoparathyroidism | leads to hypocalcemia which reduces vitamin D levels; treatment involves calcium and vitamin D supplements |
| Fosamax | alendronate *bisphosphonate osteoporosis medication |